nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Atenolol—ABCB1—ovarian cancer	0.00133	0.323	CrCbGaD
Betaxolol—Acebutolol—ABCB1—ovarian cancer	0.00123	0.298	CrCbGaD
Betaxolol—Metoprolol—ABCB1—ovarian cancer	0.00103	0.252	CrCbGaD
Betaxolol—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.0007	0.000703	CcSEcCtD
Betaxolol—Vomiting—Vinorelbine—ovarian cancer	0.000697	0.0007	CcSEcCtD
Betaxolol—Dysuria—Epirubicin—ovarian cancer	0.000693	0.000696	CcSEcCtD
Betaxolol—Rash—Vinorelbine—ovarian cancer	0.000691	0.000694	CcSEcCtD
Betaxolol—Dermatitis—Vinorelbine—ovarian cancer	0.000691	0.000694	CcSEcCtD
Betaxolol—Hypotension—Paclitaxel—ovarian cancer	0.000689	0.000692	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000689	0.000692	CcSEcCtD
Betaxolol—Headache—Vinorelbine—ovarian cancer	0.000687	0.00069	CcSEcCtD
Betaxolol—Syncope—Docetaxel—ovarian cancer	0.000687	0.00069	CcSEcCtD
Betaxolol—Dysphagia—Doxorubicin—ovarian cancer	0.000686	0.000689	CcSEcCtD
Betaxolol—Asthma—Doxorubicin—ovarian cancer	0.000686	0.000689	CcSEcCtD
Betaxolol—Influenza—Doxorubicin—ovarian cancer	0.000686	0.000689	CcSEcCtD
Betaxolol—Palpitations—Docetaxel—ovarian cancer	0.000677	0.00068	CcSEcCtD
Betaxolol—Weight increased—Epirubicin—ovarian cancer	0.000675	0.000678	CcSEcCtD
Betaxolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000673	0.000676	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000672	0.000675	CcSEcCtD
Betaxolol—Weight decreased—Epirubicin—ovarian cancer	0.000671	0.000674	CcSEcCtD
Betaxolol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000669	0.000672	CcSEcCtD
Betaxolol—Cough—Docetaxel—ovarian cancer	0.000669	0.000671	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—ovarian cancer	0.000668	0.000671	CcSEcCtD
Betaxolol—Insomnia—Paclitaxel—ovarian cancer	0.000667	0.00067	CcSEcCtD
Betaxolol—Pneumonia—Epirubicin—ovarian cancer	0.000665	0.000668	CcSEcCtD
Betaxolol—Paraesthesia—Paclitaxel—ovarian cancer	0.000662	0.000665	CcSEcCtD
Betaxolol—Infestation NOS—Epirubicin—ovarian cancer	0.000661	0.000664	CcSEcCtD
Betaxolol—Infestation—Epirubicin—ovarian cancer	0.000661	0.000664	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—ovarian cancer	0.00066	0.000663	CcSEcCtD
Betaxolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000658	0.00066	CcSEcCtD
Betaxolol—Chest pain—Docetaxel—ovarian cancer	0.000652	0.000655	CcSEcCtD
Betaxolol—Arthralgia—Docetaxel—ovarian cancer	0.000652	0.000655	CcSEcCtD
Betaxolol—Myalgia—Docetaxel—ovarian cancer	0.000652	0.000655	CcSEcCtD
Betaxolol—Nausea—Vinorelbine—ovarian cancer	0.000651	0.000654	CcSEcCtD
Betaxolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000649	0.000652	CcSEcCtD
Betaxolol—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000648	0.000651	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000648	0.00065	CcSEcCtD
Betaxolol—Stomatitis—Epirubicin—ovarian cancer	0.000645	0.000647	CcSEcCtD
Betaxolol—Conjunctivitis—Epirubicin—ovarian cancer	0.000643	0.000645	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—ovarian cancer	0.000642	0.000644	CcSEcCtD
Betaxolol—Decreased appetite—Paclitaxel—ovarian cancer	0.000641	0.000644	CcSEcCtD
Betaxolol—Dry mouth—Docetaxel—ovarian cancer	0.000638	0.00064	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000638	0.00064	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000637	0.000639	CcSEcCtD
Betaxolol—Fatigue—Paclitaxel—ovarian cancer	0.000636	0.000639	CcSEcCtD
Betaxolol—Sweating—Epirubicin—ovarian cancer	0.000634	0.000637	CcSEcCtD
Betaxolol—Pain—Paclitaxel—ovarian cancer	0.000631	0.000633	CcSEcCtD
Betaxolol—Constipation—Paclitaxel—ovarian cancer	0.000631	0.000633	CcSEcCtD
Betaxolol—Confusional state—Docetaxel—ovarian cancer	0.00063	0.000633	CcSEcCtD
Betaxolol—Oedema—Docetaxel—ovarian cancer	0.000625	0.000628	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—ovarian cancer	0.000624	0.000627	CcSEcCtD
Betaxolol—Epistaxis—Epirubicin—ovarian cancer	0.000624	0.000626	CcSEcCtD
Betaxolol—Infection—Docetaxel—ovarian cancer	0.000621	0.000624	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—ovarian cancer	0.000621	0.000623	CcSEcCtD
Betaxolol—Sinusitis—Epirubicin—ovarian cancer	0.00062	0.000623	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000619	0.000622	CcSEcCtD
Betaxolol—Agranulocytosis—Epirubicin—ovarian cancer	0.000617	0.00062	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—ovarian cancer	0.000615	0.000618	CcSEcCtD
Betaxolol—Shock—Docetaxel—ovarian cancer	0.000615	0.000618	CcSEcCtD
Betaxolol—Nervous system disorder—Docetaxel—ovarian cancer	0.000613	0.000616	CcSEcCtD
Betaxolol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000612	0.000615	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—ovarian cancer	0.000612	0.000614	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—ovarian cancer	0.000612	0.000614	CcSEcCtD
Betaxolol—Tachycardia—Docetaxel—ovarian cancer	0.00061	0.000613	CcSEcCtD
Betaxolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000608	0.00061	CcSEcCtD
Betaxolol—Skin disorder—Docetaxel—ovarian cancer	0.000607	0.00061	CcSEcCtD
Betaxolol—Bradycardia—Epirubicin—ovarian cancer	0.000604	0.000607	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.0006	0.000602	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—ovarian cancer	0.000596	0.000599	CcSEcCtD
Betaxolol—Anorexia—Docetaxel—ovarian cancer	0.000596	0.000598	CcSEcCtD
Betaxolol—Rhinitis—Epirubicin—ovarian cancer	0.000595	0.000598	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000595	0.000597	CcSEcCtD
Betaxolol—Hypoaesthesia—Epirubicin—ovarian cancer	0.000591	0.000593	CcSEcCtD
Betaxolol—Pharyngitis—Epirubicin—ovarian cancer	0.000589	0.000592	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—ovarian cancer	0.000587	0.000589	CcSEcCtD
Betaxolol—Urticaria—Paclitaxel—ovarian cancer	0.000586	0.000588	CcSEcCtD
Betaxolol—Hypotension—Docetaxel—ovarian cancer	0.000584	0.000587	CcSEcCtD
Betaxolol—Body temperature increased—Paclitaxel—ovarian cancer	0.000583	0.000586	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—ovarian cancer	0.000577	0.000579	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—ovarian cancer	0.000574	0.000576	CcSEcCtD
Betaxolol—Visual impairment—Epirubicin—ovarian cancer	0.000572	0.000574	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000571	0.000573	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00057	0.000572	CcSEcCtD
Betaxolol—Insomnia—Docetaxel—ovarian cancer	0.000565	0.000568	CcSEcCtD
Betaxolol—Paraesthesia—Docetaxel—ovarian cancer	0.000561	0.000564	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—ovarian cancer	0.000559	0.000561	CcSEcCtD
Betaxolol—Dyspnoea—Docetaxel—ovarian cancer	0.000557	0.00056	CcSEcCtD
Betaxolol—Eye disorder—Epirubicin—ovarian cancer	0.000555	0.000557	CcSEcCtD
Betaxolol—Tinnitus—Epirubicin—ovarian cancer	0.000553	0.000556	CcSEcCtD
Betaxolol—Flushing—Epirubicin—ovarian cancer	0.000551	0.000553	CcSEcCtD
Betaxolol—Cardiac disorder—Epirubicin—ovarian cancer	0.000551	0.000553	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—ovarian cancer	0.000551	0.000553	CcSEcCtD
Betaxolol—Dyspepsia—Docetaxel—ovarian cancer	0.00055	0.000553	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000546	0.000549	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—ovarian cancer	0.000545	0.000547	CcSEcCtD
Betaxolol—Decreased appetite—Docetaxel—ovarian cancer	0.000544	0.000546	CcSEcCtD
Betaxolol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000543	0.000546	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00054	0.000542	CcSEcCtD
Betaxolol—Fatigue—Docetaxel—ovarian cancer	0.000539	0.000541	CcSEcCtD
Betaxolol—Angiopathy—Epirubicin—ovarian cancer	0.000539	0.000541	CcSEcCtD
Betaxolol—Immune system disorder—Epirubicin—ovarian cancer	0.000536	0.000538	CcSEcCtD
Betaxolol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000535	0.000537	CcSEcCtD
Betaxolol—Pain—Docetaxel—ovarian cancer	0.000535	0.000537	CcSEcCtD
Betaxolol—Constipation—Docetaxel—ovarian cancer	0.000535	0.000537	CcSEcCtD
Betaxolol—Chills—Epirubicin—ovarian cancer	0.000533	0.000535	CcSEcCtD
Betaxolol—Arrhythmia—Epirubicin—ovarian cancer	0.00053	0.000532	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—ovarian cancer	0.000529	0.000531	CcSEcCtD
Betaxolol—Asthenia—Paclitaxel—ovarian cancer	0.000529	0.000531	CcSEcCtD
Betaxolol—Alopecia—Epirubicin—ovarian cancer	0.000525	0.000527	CcSEcCtD
Betaxolol—Propranolol—ABCB1—ovarian cancer	0.000522	0.127	CrCbGaD
Betaxolol—Pruritus—Paclitaxel—ovarian cancer	0.000522	0.000524	CcSEcCtD
Betaxolol—Mental disorder—Epirubicin—ovarian cancer	0.00052	0.000522	CcSEcCtD
Betaxolol—Malnutrition—Epirubicin—ovarian cancer	0.000517	0.000519	CcSEcCtD
Betaxolol—Erythema—Epirubicin—ovarian cancer	0.000517	0.000519	CcSEcCtD
Betaxolol—Feeling abnormal—Docetaxel—ovarian cancer	0.000515	0.000517	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—ovarian cancer	0.000513	0.000515	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—ovarian cancer	0.000512	0.000514	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—ovarian cancer	0.00051	0.000512	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—ovarian cancer	0.00051	0.000512	CcSEcCtD
Betaxolol—Tension—Epirubicin—ovarian cancer	0.000507	0.000509	CcSEcCtD
Betaxolol—Dysgeusia—Epirubicin—ovarian cancer	0.000506	0.000508	CcSEcCtD
Betaxolol—Diarrhoea—Paclitaxel—ovarian cancer	0.000505	0.000507	CcSEcCtD
Betaxolol—Nervousness—Epirubicin—ovarian cancer	0.000502	0.000504	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—ovarian cancer	0.000498	0.0005	CcSEcCtD
Betaxolol—Muscle spasms—Epirubicin—ovarian cancer	0.000497	0.000499	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—ovarian cancer	0.000496	0.000498	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000495	0.000497	CcSEcCtD
Betaxolol—Body temperature increased—Docetaxel—ovarian cancer	0.000494	0.000496	CcSEcCtD
Betaxolol—Chills—Doxorubicin—ovarian cancer	0.000493	0.000495	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—ovarian cancer	0.000491	0.000493	CcSEcCtD
Betaxolol—Dizziness—Paclitaxel—ovarian cancer	0.000488	0.00049	CcSEcCtD
Betaxolol—Vision blurred—Epirubicin—ovarian cancer	0.000487	0.000489	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—ovarian cancer	0.000485	0.000487	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—ovarian cancer	0.000481	0.000483	CcSEcCtD
Betaxolol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000479	0.000481	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—ovarian cancer	0.000478	0.00048	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—ovarian cancer	0.000478	0.00048	CcSEcCtD
Betaxolol—Anaemia—Epirubicin—ovarian cancer	0.000478	0.00048	CcSEcCtD
Betaxolol—Tension—Doxorubicin—ovarian cancer	0.000469	0.000471	CcSEcCtD
Betaxolol—Vomiting—Paclitaxel—ovarian cancer	0.000469	0.000471	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—ovarian cancer	0.000468	0.00047	CcSEcCtD
Betaxolol—Malaise—Epirubicin—ovarian cancer	0.000466	0.000468	CcSEcCtD
Betaxolol—Rash—Paclitaxel—ovarian cancer	0.000465	0.000467	CcSEcCtD
Betaxolol—Dermatitis—Paclitaxel—ovarian cancer	0.000465	0.000467	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—ovarian cancer	0.000464	0.000466	CcSEcCtD
Betaxolol—Vertigo—Epirubicin—ovarian cancer	0.000464	0.000466	CcSEcCtD
Betaxolol—Syncope—Epirubicin—ovarian cancer	0.000463	0.000465	CcSEcCtD
Betaxolol—Headache—Paclitaxel—ovarian cancer	0.000462	0.000464	CcSEcCtD
Betaxolol—Hypersensitivity—Docetaxel—ovarian cancer	0.000461	0.000463	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—ovarian cancer	0.00046	0.000462	CcSEcCtD
Betaxolol—Palpitations—Epirubicin—ovarian cancer	0.000457	0.000459	CcSEcCtD
Betaxolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000454	0.000456	CcSEcCtD
Betaxolol—Cough—Epirubicin—ovarian cancer	0.000451	0.000453	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—ovarian cancer	0.000451	0.000452	CcSEcCtD
Betaxolol—Asthenia—Docetaxel—ovarian cancer	0.000449	0.00045	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000444	0.000445	CcSEcCtD
Betaxolol—Pruritus—Docetaxel—ovarian cancer	0.000442	0.000444	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—ovarian cancer	0.000442	0.000444	CcSEcCtD
Betaxolol—Chest pain—Epirubicin—ovarian cancer	0.00044	0.000442	CcSEcCtD
Betaxolol—Arthralgia—Epirubicin—ovarian cancer	0.00044	0.000442	CcSEcCtD
Betaxolol—Myalgia—Epirubicin—ovarian cancer	0.00044	0.000442	CcSEcCtD
Betaxolol—Anxiety—Epirubicin—ovarian cancer	0.000438	0.00044	CcSEcCtD
Betaxolol—Nausea—Paclitaxel—ovarian cancer	0.000438	0.00044	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000437	0.000439	CcSEcCtD
Betaxolol—Discomfort—Epirubicin—ovarian cancer	0.000435	0.000436	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—ovarian cancer	0.000431	0.000433	CcSEcCtD
Betaxolol—Dry mouth—Epirubicin—ovarian cancer	0.00043	0.000432	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—ovarian cancer	0.00043	0.000431	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—ovarian cancer	0.000429	0.000431	CcSEcCtD
Betaxolol—Diarrhoea—Docetaxel—ovarian cancer	0.000428	0.00043	CcSEcCtD
Betaxolol—Confusional state—Epirubicin—ovarian cancer	0.000425	0.000427	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—ovarian cancer	0.000423	0.000424	CcSEcCtD
Betaxolol—Oedema—Epirubicin—ovarian cancer	0.000422	0.000423	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.00042	0.000422	CcSEcCtD
Betaxolol—Infection—Epirubicin—ovarian cancer	0.000419	0.000421	CcSEcCtD
Betaxolol—Cough—Doxorubicin—ovarian cancer	0.000417	0.000419	CcSEcCtD
Betaxolol—Shock—Epirubicin—ovarian cancer	0.000415	0.000417	CcSEcCtD
Betaxolol—Nervous system disorder—Epirubicin—ovarian cancer	0.000414	0.000415	CcSEcCtD
Betaxolol—Dizziness—Docetaxel—ovarian cancer	0.000413	0.000415	CcSEcCtD
Betaxolol—Thrombocytopenia—Epirubicin—ovarian cancer	0.000413	0.000415	CcSEcCtD
Betaxolol—Tachycardia—Epirubicin—ovarian cancer	0.000412	0.000413	CcSEcCtD
Betaxolol—Skin disorder—Epirubicin—ovarian cancer	0.00041	0.000411	CcSEcCtD
Betaxolol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000408	0.000409	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—ovarian cancer	0.000407	0.000409	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—ovarian cancer	0.000407	0.000409	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—ovarian cancer	0.000407	0.000409	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—ovarian cancer	0.000406	0.000407	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000404	0.000406	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—ovarian cancer	0.000402	0.000404	CcSEcCtD
Betaxolol—Anorexia—Epirubicin—ovarian cancer	0.000402	0.000404	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—ovarian cancer	0.000398	0.0004	CcSEcCtD
Betaxolol—Vomiting—Docetaxel—ovarian cancer	0.000398	0.000399	CcSEcCtD
Betaxolol—Rash—Docetaxel—ovarian cancer	0.000394	0.000396	CcSEcCtD
Betaxolol—Hypotension—Epirubicin—ovarian cancer	0.000394	0.000396	CcSEcCtD
Betaxolol—Dermatitis—Docetaxel—ovarian cancer	0.000394	0.000395	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—ovarian cancer	0.000393	0.000395	CcSEcCtD
Betaxolol—Headache—Docetaxel—ovarian cancer	0.000392	0.000393	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—ovarian cancer	0.00039	0.000392	CcSEcCtD
Betaxolol—Infection—Doxorubicin—ovarian cancer	0.000388	0.000389	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000384	0.000386	CcSEcCtD
Betaxolol—Shock—Doxorubicin—ovarian cancer	0.000384	0.000385	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000383	0.000384	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000382	0.000384	CcSEcCtD
Betaxolol—Insomnia—Epirubicin—ovarian cancer	0.000381	0.000383	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—ovarian cancer	0.000381	0.000382	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—ovarian cancer	0.000379	0.000381	CcSEcCtD
Betaxolol—Paraesthesia—Epirubicin—ovarian cancer	0.000379	0.00038	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000377	0.000379	CcSEcCtD
Betaxolol—Dyspnoea—Epirubicin—ovarian cancer	0.000376	0.000378	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—ovarian cancer	0.000372	0.000373	CcSEcCtD
Betaxolol—Nausea—Docetaxel—ovarian cancer	0.000371	0.000373	CcSEcCtD
Betaxolol—Dyspepsia—Epirubicin—ovarian cancer	0.000371	0.000373	CcSEcCtD
Betaxolol—Decreased appetite—Epirubicin—ovarian cancer	0.000367	0.000368	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—ovarian cancer	0.000365	0.000366	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000364	0.000366	CcSEcCtD
Betaxolol—Fatigue—Epirubicin—ovarian cancer	0.000364	0.000365	CcSEcCtD
Betaxolol—Constipation—Epirubicin—ovarian cancer	0.000361	0.000362	CcSEcCtD
Betaxolol—Pain—Epirubicin—ovarian cancer	0.000361	0.000362	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000356	0.000357	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—ovarian cancer	0.000353	0.000354	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—ovarian cancer	0.00035	0.000352	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—ovarian cancer	0.000348	0.000349	CcSEcCtD
Betaxolol—Feeling abnormal—Epirubicin—ovarian cancer	0.000348	0.000349	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—ovarian cancer	0.000343	0.000345	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—ovarian cancer	0.000339	0.000341	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000337	0.000338	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—ovarian cancer	0.000336	0.000338	CcSEcCtD
Betaxolol—Urticaria—Epirubicin—ovarian cancer	0.000335	0.000336	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—ovarian cancer	0.000334	0.000335	CcSEcCtD
Betaxolol—Pain—Doxorubicin—ovarian cancer	0.000334	0.000335	CcSEcCtD
Betaxolol—Body temperature increased—Epirubicin—ovarian cancer	0.000333	0.000335	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000322	0.000323	CcSEcCtD
Betaxolol—Hypersensitivity—Epirubicin—ovarian cancer	0.000311	0.000312	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—ovarian cancer	0.00031	0.000311	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—ovarian cancer	0.000308	0.00031	CcSEcCtD
Betaxolol—Asthenia—Epirubicin—ovarian cancer	0.000303	0.000304	CcSEcCtD
Betaxolol—Pruritus—Epirubicin—ovarian cancer	0.000298	0.0003	CcSEcCtD
Betaxolol—Diarrhoea—Epirubicin—ovarian cancer	0.000289	0.00029	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000287	0.000289	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—ovarian cancer	0.00028	0.000281	CcSEcCtD
Betaxolol—Dizziness—Epirubicin—ovarian cancer	0.000279	0.00028	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—ovarian cancer	0.000276	0.000277	CcSEcCtD
Betaxolol—Vomiting—Epirubicin—ovarian cancer	0.000268	0.000269	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—ovarian cancer	0.000267	0.000268	CcSEcCtD
Betaxolol—Rash—Epirubicin—ovarian cancer	0.000266	0.000267	CcSEcCtD
Betaxolol—Dermatitis—Epirubicin—ovarian cancer	0.000266	0.000267	CcSEcCtD
Betaxolol—Headache—Epirubicin—ovarian cancer	0.000264	0.000265	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—ovarian cancer	0.000258	0.000259	CcSEcCtD
Betaxolol—Nausea—Epirubicin—ovarian cancer	0.00025	0.000252	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—ovarian cancer	0.000248	0.000249	CcSEcCtD
Betaxolol—Rash—Doxorubicin—ovarian cancer	0.000246	0.000247	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—ovarian cancer	0.000246	0.000247	CcSEcCtD
Betaxolol—Headache—Doxorubicin—ovarian cancer	0.000244	0.000245	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—ovarian cancer	0.000232	0.000233	CcSEcCtD
